Emergent BioSolutions will host an Analyst & Investor Day on Thursday, November 21, 2019.
To register for onsite participation or to request for more information, please contact Robert Burrows, IRO for Emergent BioSolutions at burrowsr@ebsi.com or (240) 631-3280.
Agenda
Thursday, November 21
8:00 a.m. - 2:00 p.m. EST
New York City
Breakfast and Registration
Welcome
Corporate Growth Strategy 2020-2024
Markets & Customers
Vaccines
Therapeutics
Q&A
Break
Contract Development & Manufacturing Operations
Devices
Corporate Development Update
Financial Update
Closing
Q&A
Adjourn; Lunch
Speakers
 |
Robert Kramer, President & CEO |
 |
Rich Lindahl, EVP & CFO |
 |
Atul Saran, EVP, Corporate Development & General Counsel |
 |
Doug White, SVP, Devices Business Unit Head |
 |
Sean Kirk, EVP, Manufacturing & Technical Operations |
 |
Laura Saward, Ph.D., SVP, Therapeutics Business Unit Head |
 |
Abbey Jenkins, SVP, Vaccines Business Unit Head |
 |
Adam Havey, EVP, Business Operations |
 |
Robert Burrows, VP, Investor Relations |
Webcast
A live audio webcast will be available using the link: https://stream.rampard.com/20191121/
Presentation
2019 Analyst & Investor Day Presentation
Supplemental Materials
To Be Updated